On Tuesday, Shares of International Business Machines Corp. (NYSE:IBM), gained 0.08% to $135.42.
International Business Machines Corp., declared that Christian Cinema, which hosts the largest selection of Christian films on the internet, has accomplished an integration of high-speed file transfer technology from Aspera, an IBM company, into their cloud-based content administration platform. The integration of Aspera’s patented FASP® technology will enable filmmakers to submit their videos directly to the cloud at high speed and with strong security.
Christian Cinema built their own video platform in house, leveraging cloud infrastructure to combine all of the pieces of their media distribution workflow in one centralized location – counting content ingest, encoding, storage and streaming to the final consumer. To supplement this Video On Demand (VOD) platform, Christian Cinema selected Aspera’s Application Platform On Demand to allow filmmakers and distributors to send large video files to the cloud in a secure and fast manner.
Using the Aspera SDK, Christian Cinema embedded Aspera FASP into their custom VOD platform, creating a seamless end-to-end video administration experience for their content suppliers. Filmmaking partners that have signed a licensing agreement with Christian Cinema can go to their individual account page to upload the titles and add any metadata, artwork, pricing and trailers.
International Business Machines Corporation provides information technology (IT) products and services worldwide. The company’s Global Technology Services segment provides IT infrastructure and business process services, such as outsourcing, processing, integrated technology, cloud, and technology support.
Shares of Exelixis, Inc. (NASDAQ:EXEL), inclined 3.77% to $6.33, during its last trading session.
Exelixis, stated financial results for the third quarter of 2015 and offered an update on progress toward delivering upon its key 2015 corporate objectives and clinical development milestones.
Key Precedingities and Corporate Updates
Following release of positive results from the pivotal METEOR trial, Exelixis is focused on expediting its regulatory submissions and augmenting its commercial infrastructure to support the potential launch of its lead compound, cabozantinib, in advanced renal cell carcinoma (RCC) in the United States. At the same time, in support of its partnership partner, Genentech, a member of the Roche Group, Exelixis is rolling out its portion of the U.S. sales force promoting COTELLICTM (cobimetinib), a second Exelixis-discovered compound, following recent regulatory approvals for the compound in combination with vemurafenib for the treatment of BRAF V600 mutation-positive unrespectable or metastatic melanoma in the United States and Switzerland.
Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patients with progressive, metastatic medullary thyroid cancer.
Finally, Shares of White Wave Foods Co (NYSE:WWAV), ended its last trade with -1.13% loss, and closed at $42.89.
The White Wave Foods Company, stated record results for the third quarter ended September 30, 2015.
White Wave stated third quarter 2015 adjusted diluted earnings per share of $0.33, not taking into account operating costs associated with its China joint venture. Counting joint venture costs, White Wave stated third quarter 2015 adjusted diluted earnings per share of $0.31.
Adjusted net sales for third quarter 2015 were $1.0 billion, a 17 percent improvement from net sales of $857 million in third quarter 2014. These strong results were driven by growth across all segments, in addition to contributions from acquisitions. On a constant currency basis, adjusted net sales raised 20 percent in third quarter 2015 over the same period in 2014. Not Taking Into Account acquisitions, adjusted organic constant currency net sales raised 11 percent in third quarter 2015 over the same period in 2014.
Adjusted operating income for third quarter 2015 raised 25 percent to $102 million, contrast to $82 million in third quarter 2014. On a constant currency basis, adjusted operating income raised 31 percent in third quarter 2015 over the same period in 2014.
Our strong growth momentum in the first half of the year accelerated in the third quarter, with 17 percent sales growth resulting in our first ever quarter of sales over a billion dollars, said Gregg Engles, chairman and chief executive officer. Our market leading brands and industry leading innovation continue to drive strong organic growth across our businesses resulting in 11 percent adjusted organic constant currency net sales growth in the quarter. We also continued to execute on our planned initiatives by closing on our Vega and Wallaby acquisitions, and plannedally modified our credit facility to support our continued growth plans. Our focus remains on changing the way the world eats for the better, while delivering outstanding growth in sales and profits to our investors.
The White Wave Foods Company, a consumer packaged food and beverage company, manufactures, markets, distributes, and sells branded plant-based foods and beverages, salads, fruits and vegetables, coffee creamers and beverages, and dairy products and organic produce in North America and Europe.